Androgens and Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel

BACKGROUND: Pre-treatment androgen levels are associated with overall survival (OS) in metastatic castration-resistant prostate cancer (CRPC) patients treated with androgen synthesis inhibitors. The current study sought to determine whether pre-treatment serum androgens predict clinical outcome amon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Genitourin Cancer
Hauptverfasser: Ryan, Charles J, Dutta, Sandipan, Kelly, William K, Middleberg, Rob, Russell, Carly, Morris, Michael J., Taplin, Mary-Ellen, Halabi, Susan
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252587/
https://ncbi.nlm.nih.gov/pubmed/32273234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2019.10.002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge